← ANALYSTS · TIPRANKS

Douglas Tsao · H.C. Wainwright

#207among 12,504 TipRanks analysts★★★★★★★★★★
Hits 56% 278 of 498 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating +24.3% Over a year after the rating, TipRanks’ measure
Our companies rated now 19 Buy / hold / sell: 15 / 4 / 0
Upside of the analyst’s targets +234.4% Average over 19 current targets, to the last price
The market’s answer to the ratings +0.6% Day-0 move against SPY in the rating’s direction, average over 3 upgrades, downgrades and target changes
Date · added, NYStockAction RatingPrice target Upside Move vs SPY
Oct 15on TipRanks 07:15 PRAXIWMPraxis Precision Medicines · $6.9B Reiterated Buy $1,201 +396.8% +3.6%next day −1.5%
Oct 15on TipRanks 07:14 RZLTIWMRezolute · $377M Reiterated Buy $10.00 +179.3% −8.1%next day −7.1%
Oct 13on TipRanks 06:26 IRONIWMDisc Medicine · $2.2B Reiterated Buy $120 +111.1% −6.4%next day −0.4%
Oct 9on TipRanks 06:15 PCRXIWMPacira Pharmaceuticals · $1.4B Downgrade Hold $38.00 → $36.50−3.9% +0.4% −0.8%next day +0.2% · 5 days +2.1%
Oct 8on TipRanks 11:06 ARGXArgenx Se · $51.7B Reiterated Buy $1,202 +46.7% −11.4%next day +0.2% · 5 days +3.7%
Sep 23on TipRanks 13:16 IMVTIWMImmunovant · $5.8B Reiterated Buy $41.00 +53.4% −6.7%next day −1.5% · 5 days −1.5%
Sep 23on TipRanks 06:25 RAPPIWMRapport Therapeutics, Inc. · $1.4B Reiterated Buy $66.00 +139.4% −17.0%next day −0.8% · 5 days −0.9%
Sep 21on TipRanks 13:55 CHRSIWMCoherus Biosciences · $165M Reiterated Buy $7.00 +607.1% −0.1%next day −5.1% · 5 days −15.8%
Sep 21on TipRanks 13:55 CABAIWMCabaletta Bio · $275M Reiterated Buy $16.00 +1,034.8% −5.1%next day +1.6% · 5 days −17.7%
Sep 21on TipRanks 12:45 ALKSIWMAlkermes · $6.7B Reiterated Hold $43.00 +4.3% +0.3%next day −2.0% · 5 days −8.1%
Sep 18on TipRanks 06:15 XENEIWMXenon · $3.3B Reiterated Buy $74.00 +121.0% −30.8%next day −3.5% · 5 days −8.3%
Sep 10on TipRanks 12:45 BHVNIWMBiohaven Ltd. · $1.7B Reiterated Hold $10.00 −7.2% −14.1%next day −1.5% · 5 days +8.0%
Sep 9on TipRanks Sep 8 12:40 ROIVRoivant Sciences · $25.0B Assigned Buy $47.00 +40.2% +19.3%next day +1.3% · 5 days −3.7%
Sep 1on TipRanks Aug 31 08:30 PTGXIWMProtagonist Therapeutics · $8.8B Assigned Buy $167 → $170+1.8% +32.0% +2.7%next day −0.2% · 5 days −1.1%
Aug 25on TipRanks 06:16 EOLSIWMEvolus · $500M Reiterated Buy $13.00 +83.1% +1.9%next day −2.2% · 5 days +1.7%
Aug 24on TipRanks 08:06 NMRAIWMNeumora Therapeutics, Inc. · $80M Reiterated Buy $7.00 +1,379.9% −6.1%next day −2.0% · 5 days −13.3%
Aug 10on TipRanks Aug 11 04:08 ARQTIWMArcutis Biotherapeutics · $3.7B Reiterated Buy $34.00 +18.0% +2.5%next day +1.5% · 5 days −1.1%
Aug 10on TipRanks 06:45 NERVIWMMinerva Neurosciences · $116M Reiterated Hold $7.00 +197.9% +8.2%next day −6.2% · 5 days −4.3%
Aug 7on TipRanks Aug 6 16:46 VRDNIWMViridian Therapeutics · $2.2B Reiterated Buy $22.00 +15.6% +4.2%next day −2.2% · 5 days −6.8%

Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗